Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Chlorhexidine digluconate solution

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 28 USDMF, 9 CEP/COS, 8 JDMF, 6 EU WC, 1 VMF, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

53 Drugs in Development

53 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

275 FDF Dossiers, 49 FDA Orange Book, 125 Europe, 69 Canada, 11 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%, SOLUTION;TOPICAL - 2%, TABLET;DENTAL - 2.5MG, SOLUTION;TOPICAL - 2%;70%, SPONGE;TOPICAL - 2%;70% (1.5ML), SPONGE;TOPICAL - 2%;70% (10.5ML), SPONGE;TOPICAL - 2%;70% (1ML), SPONGE;TOPICAL - 2%;70% (26ML), SPONGE;TOPICAL - 2%;70% (3ML), SOLUTION;TOPICAL - 61%;1%, SWAB;TOPICAL - 3.15%;70% (1.6ML), SWAB;TOPICAL - 3.15%;70% (1ML), SWAB;TOPICAL - 3.15%;70% (5.1ML), SWAB;TOPICAL - 2%;70% (0.67ML), SWAB;TOPICAL - 2%;70% (1.75ML), SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 4 SPI Pharma, 14 DKSH, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 10 Kirsch Pharma, 4 ACG Worldwide, 18 Actylis, 1 Ashland, 23 BASF, 2 BioSpectra, 4 CD Formulation, 1 Clariant, 6 Corel Pharma Chem, 1 Esteem Industries, 4 Finar, 5 Gangwal Chemicals, 1 Ideal Cures, 3 Kerry, 1 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pluviaendo, 1 Qualicaps, 19 Roquette, 16 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

53 Topical, 38 Thickeners and Stabilizers, 37 Parenteral, 36 Solubilizers, 21 Coating Systems & Additives, 20 Fillers, Diluents & Binders, 19 Film Formers & Plasticizers, 14 Rheology Modifiers, 13 Surfactant & Foaming Agents, 11 Controlled & Modified Release, 10 Taste Masking, 10 Emulsifying Agents, 8 Empty Capsules, 6 Co-Processed Excipients, 5 Direct Compression, 4 Granulation, 4 Chewable & Orodispersible Aids, 4 Lubricants & Glidants, 4 API Stability Enhancers, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 23 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 3 Regulatory FDF Prices

MARKET PLACE

34 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 US Exclusivities

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
19/09/2025	Bajaj Healthcare	India	M/s Bajai Healthcare Limited	WC-0277	Chlorhexidine Gluconate Solution Ph. Eur/BP	2025-07-04	2028-07-03	Block No. 588, Savli Karachia Road, At & Post-Gothada-391776, Tal- Savli, Dist- Vadodara, Gujarat India
19/11/2025	Basic Pharma Life Science	India	Ms. Basic Pharma Lifescience Pvt Ltd	WC-0516	Chlorhexidine Gluconate Solution BP	2025-11-06	2028-11-05	Plot No. 146/A & B, NR, GIDC Officе,Opp. New Fire Station, GIDC Estate,At & Post -Ankleshwar, Dist. -Bharuch -393002,Gujarat, India

Chlorhexidine Digluconate Solution

Chlorhexidine digluconate solution

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers

28 USDMF

9 CEP/COS

8 JDMF

6 EU WC

1 VMF

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

53 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

275 FDF Dossiers

49 FDA Orange Book

125 Europe

69 Canada

11 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%

SOLUTION;TOPICAL - 2%

TABLET;DENTAL - 2.5MG

SOLUTION;TOPICAL - 2%;70%

SPONGE;TOPICAL - 2%;70% (1.5ML)

SPONGE;TOPICAL - 2%;70% (10.5ML)

SPONGE;TOPICAL - 2%;70% (1ML)

SPONGE;TOPICAL - 2%;70% (26ML)

SPONGE;TOPICAL - 2%;70% (3ML)

SOLUTION;TOPICAL - 61%;1%

SWAB;TOPICAL - 3.15%;70% (1.6ML)

SWAB;TOPICAL - 3.15%;70% (1ML)

SWAB;TOPICAL - 3.15%;70% (5.1ML)

SWAB;TOPICAL - 2%;70% (0.67ML)

SWAB;TOPICAL - 2%;70% (1.75ML)

SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

4 SPI Pharma

14 DKSH

1 Pharm-RX Chemical

3 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

3 Pfanstiehl

10 Kirsch Pharma

4 ACG Worldwide

18 Actylis

1 Ashland

23 BASF

2 BioSpectra

4 CD Formulation

1 Clariant

6 Corel Pharma Chem

1 Esteem Industries

4 Finar

5 Gangwal Chemicals

1 Ideal Cures

3 Kerry

1 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

1 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

1 Pluviaendo

1 Qualicaps

19 Roquette